Skip to main content
MDGL logo
MDGL
(NASDAQ)
Madrigal Pharmaceuticals, Inc.
$534.16-- (--)
Loading... - Market loading

Madrigal Pharmaceuticals (MDGL) Stock Price & Financial Analysis

Madrigal Pharmaceuticals Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$526.67 - $540.00
52-Week High$615.00
52-Week Low$393.61
Open$534.17
Volume198.80K
Average Volume (3M)325.94K
Market Cap15.77B
Shares Outstanding29.15M
Price to Sales (P/S)12.28
Price to Book (P/B)30.11
EV/EBITDA-51.76
Revenue (TTM)1.28B
Net Income (TTM)-325.10M
Free Cash Flow (TTM)-206.28M
EPS (TTM)$-11.92
Profit Margin-25.32%
Operating Margin-25.13%
Return on Equity (ROE)-62.07%
Debt to Equity0.65
50-Day MA$530.02
200-Day MA$515.18
52-Week Change17.71%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Madrigal Pharmaceuticals

What is the current stock price for MDGL?

As of the latest trading session, MDGL stock trades at $534.16. The 52-week range is $393.61–$615.00, with a day range of $526.67–$540.00.

What is the P/E ratio for MDGL?

The P/E ratio (Price-to-Earnings) for MDGL is shown in the Key Statistics section. This valuation metric helps compare Madrigal Pharmaceuticals, Inc. to industry peers.

Does MDGL pay dividends?

Madrigal Pharmaceuticals does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for MDGL?

Based on 4 analysts, the consensus for MDGL is Buy.

What is the market cap of MDGL?

Madrigal Pharmaceuticals's market capitalization is $15.57B, classifying it as a large-cap company. Madrigal Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.